PF-Atlas › Clinical Trials › NCT03527095

A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects

FDL169 · Phase 1

Registry ID

NCT03527095

Phase

Phase 1

Status

Completed

Drug / intervention

FDL169

Sponsor

Flatley Discovery Lab LLC

Start

2018-04-05

Enrollment

Locations

About this trial

This is a randomised, cross-over study comprised of 6 periods in healthy subjects.Subjects will receive Regimens A, B and C in a randomised crossover manner in the fed state, followed by Regimens D, E and F in a randomised crossover manner, in the fasted or fed state, as applicable.

View NCT03527095 on ClinicalTrials.gov →

Explore related

All FDL169 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT03527095 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.